Lysosomes function in degradation of macromolecules, such as proteins, lipids, glycosaminoglycans or nucleic acids, intracellular organelles and pathogens obtained by endocytosis, autophagy and phagocytosis through the concerted action of more than 50 acid hydrolases (1) . To maintain their function, lysosomes require a continuous replenishment of newly synthesized components transported from the endoplasmic reticulum (ER) via the Golgi apparatus to the endosomal/lysosomal compartment. The efficient transport of soluble lysosomal enzymes to lysosomes requires mannose 6-phosphate (M6P) residues on their Nlinked glycans which serve as recognition markers for M6P-specific receptors (MPR) (2) . The formation of M6P residues is catalyzed by two enzymes, the N-acetylglucosamine-1-phosphotransferase (termed GlcNAc-1-phosphotransferase) and the GlcNAc-1-phosphodiester α-N-acetylglucosaminidase (termed uncovering enzyme) localized in the cis-Golgi apparatus and trans-Golgi network (TGN), respectively (3).
The GlcNAc-1-phosphotransferase is a heterohexameric complex of three subunits (α 2 β 2 γ 2 ) which are encoded by two genes (4) (5) (6) . The α-and β-subunits of the GlcNAc-1-phosphotransferase are synthesized in the ER as a single highly N-glycosylated 190-kDa type III membrane protein (6) . For the transport to the Golgi apparatus combinatorial dileucine and dibasic sorting motifs in the N-and C-terminal cytosolic domains, respectively, are required (7) . Upon arrival in the cis-Golgi compartment, the α/β-subunit precursor is proteolytically cleaved by the site-1 protease (S1P) into mature α-and β-subunits (8) prerequisite for the enzymatic activity of the GlcNAc-1-phosphotransferase complex (9) . S1P (also known as subtilisin kexin isoenzyme-1, SKI-1) is a type I membrane serine protease and plays a crucial role in the proteolytic activation of the sterol regulatory element (SRE)-binding proteins, SREBP-1 and -2, necessary for synthesis of fatty acids, triglycerides, and cholesterol, respectively (10, 11) . SREBPs are type III membrane-bound transcription factors with both cytosolic N-terminal transcription factor domains and C-terminal regulatory domains (12) . At conditions of cholesterol abundance SREBPs form ER-anchored complexes with the polytopic sterol-sensing SREBP cleavage-activating protein (SCAP) and INSIG, an insulin-induced gene product. Upon cholesterol depletion, the complex dissociates and SCAP escorts SREBPs from the ER to the Golgi apparatus followed by S1P-initiated release of the active transcription factor domain entering the nucleus (13, 14) .
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In cells deficient for S1P, the α/β-subunit precursor of GlcNAc-1-phosphotransferase cannot be cleaved and activated, which is subsequently associated with the lack of M6P residues, missorting of newly synthesized lysosomal enzymes, and accumulation of non-degraded storage material in lysosomes (8) , hallmarks of mucolipidosis type II (MLII). MLII (also called I-cell disease) is a severe multi-systemic inherited disorder of childhood caused by mutations in the GNPTAB gene encoding the α/β-subunit precursor protein of the GlcNAc-1-phosphotransferase (6, 15) . Although the nature of storage material in MLII cells and tissues has not been fully characterized, analysis of fibroblasts of MLII patients and MLII mice revealed in addition to increased level of phospholipids, fucosylated oligosaccharides, and sialic acid-containing glycosphingolipids, an elevation and lysosomal accumulation of cholesterol (16) (17) (18) .
In the present study, we investigated whether alterations in the cholesterol content of murine and human fibroblasts affects the ER-Golgi transport, the proteolytic activation of the α/β-subunit precursor of GlcNAc-1-phosphotransferase, and the subsequent lysosomal targeting of lysosomal enzymes. The results were compared with data from fibroblasts of Niemann-Pick type C1 (NPC1) patients and MLII mice both characterized by abnormal cholesterol metabolism (18, 19) . These analyses demonstrate that the export and the S1P-mediated cleavage of the α/β-subunit precursor protein of GlcNAc-1-phosphotransferase is independent of the cellular cholesterol content. Furthermore, missorting of lysosomal enzymes and lysosomal dysfunction in MLII fibroblasts lead to up-regulation of endocytic receptors such as LDL receptor (LDLR) and the 300-kDa MPR (MPR300), and accumulation of their degradation intermediates.
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Cholesterol-independent M6P formation on lysosomal enzymes LDL were prepared from human plasma as previously described (20) . Recombinant human arylsulfatase B (ASB) was kindly provided by Dr. Vellard (BioMarin/Genzyme LLC, Novato, CA).
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MATERIALS AND METHODS
Reagents
Antibodies
A myc-tagged single-chain antibody fragment against M6P residues (scFv M6P-1) and the monoclonal rat antibody against the α-subunit of the GlcNAc-1-phosphotransferase has been described recently (21, 22 N-and C-terminal ER exit structures, and structural requirements for efficient proteolytic cleavage by S1P (8, 22) . The medium was replaced 6 h after transfection, and cells were further incubated with cholesterol depletion medium or LDL loading medium for 18 h.
mRNA Analysis
Total RNA isolation, cDNA synthesis and real-time PCR were performed as previously described (8) .
TaqMan™ Gene Expression Assays including pre-designed probes and primer sets for mouse Ldlr (Mm00440169_m1), Gnptab (Mm01773334_m1), Actb (Mm00607939_s1) and human LDLR (Hs00181192_m1), ACTB (Hs9999903_m1) were used. The relative expression of human and murine LDLR, and Gnptab mRNA was normalized to the level of ACTB mRNA in the same cDNA using the comparative C T method (2 -ΔΔCT ). 
Western Blotting
Cells were lysed for 30 min at 4°C in PBS containing 1% Triton X-100 and protease inhibitor cocktail.
After centrifugation at 10,000 x g supernatants were used for measurement of the protein content by the 
Other Methods
Confocal immunofluorescence microscopy of transfected cells, activity determination of the enzyme β-hexosaminidase and metabolic [ 
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Statistical analysis
For statistical analysis student´s t-test was performed. P-values < 0.05 were considered significant.
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RESULTS
High LDL receptor expression in MLII mouse embryonic fibroblasts
To investigate, whether the α/β-subunit precursor protein of GlcNAc-1-phosphotransferase is transported from the ER to the Golgi apparatus independently of cholesterol/LDL or not, the effects of the cholesteroldepleting drug atorvastatin (ATV) and the LDL-mediated cholesterol overload were examined in mouse embryonic fibroblasts ( The cholesterol-dependent alterations in the Ldlr mRNA expression in WT MEF could be confirmed on the LDLR protein level (Fig. 2) . ATV treatment resulted in 12-fold increase whereas LDL overload suppressed the LDLR concentration to 30% of control cells ( Fig. 2A) . No or marginal effects on the LDLR expression has been observed when the cells were incubated in the presence of 10% NBCS or LPDS alone (supplementary Fig. 1 ). In MLII MEF the basal LDLR protein level was 3-fold higher than in wild-type MEF ( Fig. 2A,B) . Incubation of MLII MEF with ATV or LDL led to a 7-fold increase and 6-fold reduction of the LDL receptor expression, respectively.
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Cholesterol-independent transport and proteolytic cleavage of the GlcNAc-1-phosphotransferase
The site-1 protease substrates SREBPs are translocated from the ER to the Golgi apparatus in dependency of the membrane cholesterol content (12) . To examine whether the α/β-subunit precursor is transported to the Golgi apparatus in a cholesterol-dependent manner, MEF of WT mice (not shown), and human fibroblasts were treated with and without ATV, LDL, and transfected with the human α*/β-subunit precursor construct (8, 22) of the GlcNAc-1-phosphotransferase. Immunofluorescence microscopy revealed complete co-staining of α*-subunit immunopositive material with the cis-Golgi marker protein GM130 independent of high (LDL) or low (ATV) levels of cholesterol (Fig. 3A) . When fibroblasts of a Niemann-Pick type C1 (NPC1) patient characterized by high level of non-esterified cholesterol in lysosomes (19) and 2-to 3.5-fold increased Ldlr mRNA level (supplementary Fig. 2 ), were analyzed, α*-subunit immunoreactive material was found in GM130-positive Golgi membranes (Fig. 3B) . These data were complemented by western blot analysis of cell extracts of ATV or LDL treated WT MEF transiently transfected with the α*/β-subunit precursor construct. At steady state, small amounts of immunoreactive 120-kDa α*/β-subunit precursor polypeptides were observed in WT MEF (Fig. 3C ) and human control fibroblasts (Fig. 3D) . In contrast, strong signals of mature 90-kDa α*-subunits were detected both in MEF (Fig. 3C ) and human fibroblasts (Fig. 3D) . The proteolytic pattern of α*/β-subunit precursor and mature α*-subunit was neither affected by high nor low cholesterol content (Fig. 3C) . Similarly, α*/β-subunit precursor expressed in NPC1 fibroblasts were proteolytically cleaved to mature α*-subunits (Fig. 3D ).
Identical cleavage patterns have been observed in two other NPC1 fibroblast cell lines (Fig. 3E ). Of note, the endogenous α/β-subunit precursor or mature α-subunit cannot be visualized by the anti α-subunit monoclonal antibody due to their low expression. Finally, we tested whether MLII MEF exhibiting high lysosomal cholesterol content (18) and characterized by low cholesterol sensing ( Fig. 2A,B) were impaired in their capability to cleave the α*/β-subunit precursor protein. As shown in Fig. 3C , the majority of immunoreactive material is presented by the mature α*-subunit. These data demonstrate that neither increase nor reduction of cellular cholesterol level affected the ER-Golgi transport and the proteolytic activation of the α*/β-subunit precursor protein of GlcNAc-1-phosphotransferase.
Biogenesis of lysosomes is independent of cellular cholesterol content
The enzymatic activity of the GlcNAc-1-phosphotransferase was determined indirectly by mannose 6-phosphate (M6P) western blotting showing that neither the reduction of cholesterol content by ATV nor the LDL-treatment affected the intensity or pattern of M6P-containing proteins in WT fibroblasts ( (Fig. 4B) . The synthesis rate of CtsZ, the proteolytic processing to the mature form and the amount of secreted precursor forms
were not affected by ATV-or LDL-treatment of WT MEF (Fig. 4B) . In contrast, in MLII MEF used as control, the newly synthesized CtsZ was completely missorted into the medium during the 4 h chase period and no CtsZ immunoreactive polypeptides were retained intracellularly (Fig. 4B ). This was confirmed by the steady-state expression level of CtsZ. The amount of intracellular detectable 36-kDa mature CtsZ in ATV-, LDL-and non-treated WT MEF was similar (Fig. 4C ) whereas no CtsZ immunoreactive material was observed in MLII MEF. Furthermore, the activity of another lysosomal enzyme, β-hexosaminidase, in ATV-or LDL-treated MEF and in their respective media was comparable with non-treated control cells (Fig. 4D) . In contrast, the β-hexosaminidase activity in MLII MEF was markedly reduced by approximately 80% and missorted into the medium. These data indicate that neither ATV nor LDL treatment affected the GlcNAc-1-phosphotransferase activity in the Golgi apparatus and the transport and processing of lysosomal enzymes along the biosynthetic pathway to lysosomes.
To examine whether the transport of lysosomal enzymes along the endocytic pathway is altered in (Fig. 6A) . The Mpr300 expression was neither affected by ATV-induced reduction of cholesterol content nor by LDL overload. In addition to the major 300-kDa Mpr immunoreactive protein, ~240-and 160-kDa Mpr300 immunoreactive polypeptide bands were observed in MLII MEF (Fig. 6A) . Furthermore, the cholesterol-dependent variations in the 160-kDa LDLR expression (Fig. 2 ) correlated with the appearance of high amounts of 17-kDa and minor 40-kDa LDLR fragments and intermediates, respectively, in MLII MEF ( Fig. 6B; 26 ). Small percentages of the 17-kDa LDLR fragment were detectable in ATV-treated WT MEF. These data support previous observations that both (Fig. 3) . Subsequently, neither the pattern of M6P modifications on lysosomal proteins, the transport kinetics of the newly synthesized lysosomal protease cathepsin Z, and its lysosomal steady state concentration, nor the activity of the lysosomal marker enzyme β-hexosaminidase,
were altered in cells of low or high cholesterol content in comparison with control cells (Fig. 4) . In a second control approach we used fibroblasts from GlcNAc-1-phosphotransferase 'knock-in' mice which mimic the biochemical and clinical symptoms of human MLII disease (18, 31, 32). Fibroblasts of the MLII mouse express truncated, inactive α-subunits that are localized in the ER due to the loss of the combinatorial ER exit motif (7, 18) . The missorting and lysosomal depletion of the soluble Npc2 protein in these cells (33) result in lysosomal accumulation of non-esterified cholesterol (18). In consequence, the impaired egress from lysosomal compartments causes a lower cholesterol content in ER membranes which stimulates SREBP processing (13) . In MLII cells, activated SREBP signaling leads to a 3-fold upregulated LDLR expression that is further increased by atorvastatin treatment ( Fig. 1; Fig. 2 intact cholesterol sensing mechanism in these mutant cells.
The overexpression of the human α/β-subunit precursor protein of GlcNAc-1-phosphotransferase in MLII MEF, however, did not affect the transport to the Golgi apparatus and the S1P-mediated formation of mature α-subunits (Fig. 3C) . As a second cell model accumulating massive amounts of cholesterol and other lipids, we used fibroblasts of patients with mutations in the polytopic membrane protein NPC1 that mediates the egress of non-esterified cholesterol from lysosomes to the ER and plasma membranes (19) .
Similar to MLII MEF, the expression of α/β-subunit precursor protein in NPC1 patient fibroblasts, resulted in the cleavage into mature subunits (Fig. 3D ) confirming the independency of the α/β-subunit precursor transport from the ER to the Golgi apparatus of the cholesterol content.
Of interest, with the exception of LDL overload of WT MEF both the induced alterations in the cellular cholesterol content as well as the lysosomal accumulation of cholesterol in NPC1 fibroblasts failed to impair the receptor-mediated internalization and the transport of an M6P-containing lysosomal enzyme, arylsulfatase B (ASB), along the endocytic pathway, or the proteolytic processing into mature enzyme forms ( Fig. 5A-C) . It is likely that the increased cellular cholesterol content in LDL overloaded WT MEF results in a moderate redistribution of Mpr300 toward the endosomal compartment with a subsequent higher number of receptors recycling via the cell surface. In MLII MEF, however, the internalization rate of ASB is increased due to the elevated MPR300 level (Fig. 6Α ) caused by higher Mpr300 mRNA level (33) , and the intermediate and mature forms of ASB generated by lysosomal protease(s) accumulate. This observation is unexpected, because the majority of lysosomal proteases, such as cathepsin D, L, B, S, C, reach lysosomes in MLII cells in an M6P/sortilin-independent manner, with the exception of cathepsin Z ( Fig. 4B and C) , carboxypeptidase Q, and dipeptidylpeptidase 7 (33) . It remains to be examined whether these missorted peptidases/proteases are involved in the degradation of ASB polypeptides, or of the 17-kDa LDLR fragments (Fig. 6B ) formed in the process of proprotein convertase subtilisin/kexin type 9 (PCSK9) initiated and mediated internalization and degradation of LDLR (26, 34) .
Similarly to SREBPs which are retained in the ER by SCAP, the ER exit of another S1P substrate, ATF6, is prevented by binding of the ER chaperone BiP that dissociates in response to ER stress and allows the by guest, on November 10, 2017
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Cholesterol-independent M6P formation on lysosomal enzymes 16 translocation of ATF6 to the Golgi apparatus (35) . Our data showed that the transport of the α/β-subunit precursor of GlcNAc-1-phosphotransferase is independent of cholesterol and ER stress * . However, mutational analysis suggests that the transport of the α/β-subunit precursor is not constitutive, but depends on the binding of a yet unknown protein in the lumen of the ER, required for the ER transport of the precursor protein to the Golgi apparatus (36) . Gapdh/GAPDH western blot analysis, respectively, was used as a loading control. Extracts of nontransfected cells were used as negative control. The positions of molecular mass marker proteins (in kDa), α*/β-subunit precursor and mature α*-subunit are indicated. by guest, on November 10, 2017
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